XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.1
Investments - Additional Information (Details)
€ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Jan. 31, 2022
USD ($)
Mar. 31, 2022
USD ($)
Portfolio
Mar. 31, 2021
USD ($)
Dec. 31, 2021
USD ($)
Mar. 31, 2022
EUR (€)
Investment Holdings [Line Items]          
Aggregate estimated fair value of investments in unrealized loss position   $ 445,100,000      
Return of Fountain Healthcare Partners II, L.P. investment   $ 485,000      
Synchronicity Pharma Inc | Investee | Maximum          
Investment Holdings [Line Items]          
Equity method investment percentage 50.00%        
Synchronicity Pharma Inc | Convertible Promissory Notes | Investee          
Investment Holdings [Line Items]          
Purchase of convertible promissory notes $ 500,000        
Convertible promissory notes, maturity date Sep. 30, 2022        
Fountain Healthcare Partners II          
Investment Holdings [Line Items]          
Funding commitment as percentage of partnership's total funding   7.00%     7.00%
Equity method commitment | €         € 7.8
Number of portfolio sold | Portfolio   1      
Proceeds from sale of portfolio   $ 1,000,000.0   $ 1,100,000  
Escrow deposit   100,000      
Gain (loss) on sale of investment     $ (300,000)    
Return of Fountain Healthcare Partners II, L.P. investment   500,000      
Fountain Healthcare Partners II | Other Assets          
Investment Holdings [Line Items]          
Carrying value of equity investment   5,800,000   $ 6,100,000  
Fountain Healthcare Partners II | Other Expense, Net          
Investment Holdings [Line Items]          
Gain (loss) on sale of investment   600,000      
Fountain Healthcare Partners II | Maximum          
Investment Holdings [Line Items]          
Gain (loss) on sale of investment   $ 100,000